WG
WhiteLab Genomics
United States · Biotech
WhiteLab Genomics uses AI to design genetic medicines and develop bio-assets for cell, RNA and DNA therapies.
Product
WhiteLab Genomics has built an AI platform to accelerate the discovery and design of genomic therapies, including cell, RNA and DNA treatments. The company develops computationally designed bio-assets and is advancing programs toward in vivo validation. Its work connects AI-driven design with experimental validation to help create the next generation of genomic medicines.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series B | $26M | AVP — LeadBlast Club — ParticipantDebiopharm Innovation Fund — ParticipantOmnes Capital — ParticipantYaday Health — Participant |